Barclays’s Nutraceutical International Co NUTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,951
| Closed | -$331K | – | 7278 |
|
|
2017
Q2 | $331K | Buy |
7,951
+7,808
| +5,460% | +$279K | ﹤0.01% | 3911 |
|
|
2017
Q1 | $4K | Sell |
143
-432
| -75% | -$14.6K | ﹤0.01% | 6368 |
|
|
2016
Q4 | $20K | Sell |
575
-728
| -56% | -$23.1K | ﹤0.01% | 5636 |
|
|
2016
Q3 | $40K | Sell |
1,303
-497
| -28% | -$12.8K | ﹤0.01% | 5115 |
|
|
2016
Q2 | $42K | Sell |
1,800
-7,762
| -81% | -$185K | ﹤0.01% | 4930 |
|
|
2016
Q1 | $229K | Buy |
9,562
+4,762
| +99% | +$115K | ﹤0.01% | 3748 |
|
|
2015
Q4 | $120K | Buy |
4,800
+4,757
| +11,063% | +$117K | ﹤0.01% | 4288 |
|
|
2015
Q3 | $1K | Sell |
43
-118
| -73% | -$2.82K | ﹤0.01% | 6731 |
|
|
2015
Q2 | $4K | Sell |
161
-101
| -39% | -$2.13K | ﹤0.01% | 6622 |
|
|
2015
Q1 | $5K | Sell |
262
-231
| -47% | -$4.35K | ﹤0.01% | 6641 |
|
|
2014
Q4 | $10K | Buy |
493
+205
| +71% | +$4.45K | ﹤0.01% | 6747 |
|
|
2014
Q3 | $6K | Sell |
288
-670
| -70% | -$15.6K | ﹤0.01% | 7151 |
|
|
2014
Q2 | $22K | Buy |
958
+625
| +188% | +$15.3K | ﹤0.01% | 6468 |
|
|
2014
Q1 | $8K | Sell |
333
-112
| -25% | -$2.91K | ﹤0.01% | 7048 |
|
|
2013
Q4 | $12K | Buy |
445
+359
| +417% | +$8.91K | ﹤0.01% | 6953 |
|
|
2013
Q3 | $2K | Sell |
86
-331
| -79% | -$7.52K | ﹤0.01% | 7241 |
|
|
2013
Q2 | $8K | Buy |
+417
| New | +$7.88K | ﹤0.01% | 7234 |
|
Barclays's NUTR Position: Q3 2017 in Review
Barclays sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 7,951 shares — an estimated $331K sold.
Barclays first reported a position in NUTR in Q2 2013 and held it in 17 quarters. The position peaked at $331K in Q2 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.
- Barclays reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
- Barclays sold 7,951 Nutraceutical International Co shares in Q3 2017, an estimated $331K.
- Barclays first reported a position in Nutraceutical International Co in Q2 2013 and held it in 17 quarters.
- Barclays's Nutraceutical International Co position peaked at $331K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.